Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...
VERVE-102 is an investigational gene-editing treatment designed to permanently disable the PCSK9 gene in the liver, thereby ...
Rezdiffra leads MASH as TAM expands; growth for 2–3 years but big competition risks. Click for more on MDGL here.
NAME a health concern and there’s probably a supplement for it – and that goes for issues in the bedroom too. Most men will ...
The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia ...
Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results